GLP1R and Alzheimer disease: Considering the pathological and pharmacological mechanisms for dementia such as AD, this successful observation might be achieved by three factors, (1) recovery of neurodegeneration, (2) reduction in the cerebral and hippocampal Aβ levels in soluble and insoluble forms, and (3) activation of insulin signaling via the stimulation of insulin and GLP-1 receptors.